Product Details
Sitex Powder for Oral Suspension##
Cefuroxime (Cefuroxime Axetil); Clavulanic acid125 mg/5 mL; 31.25 mg/5 mL
Oral powder
ROA
Oral
Applicant Name
Seal Healthcare Limited
NRN
B4-6852
Status
Active
Composition
Each 5 mL reconstituted suspension contains: Cefuroxime Axetil BP equivalent to Cefuroxime 125 mg, Clavulanate Potassium Diluted BP equivalent to Clavulanic Acid 31.25 mg Excipients q.s. Color: Tartrazine
ATC Code
J01DC02
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 100 mL (in HDPE bottle)
Product Description
Powder for Oral Suspension Light orange colored granular powder which becomes yellow colored suspension on addition of water 32 RNW-PP-250750 SITEX POWDER FOR ORAL SUSPENSION CEFUROXIME AXETIL 125MG, CLAVULANIC ACID 31.25MG CEFUROXIME AXETIL 125MG, CLAVULANIC ACID 31.25,G, EXCIPIENTS QS B4-6852 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1*100ML POM 1 3/2/2022 SEAL HEALTHCARE LIMITED, 2, ASIMOLOWE STREET, OFF 5TH AVENUE, ABESAN ESTATE, LAGOS 80204011 femoade4real@yahoo.com FINECURE PHARMACEUTICAL LTD, VILLAGE SHIMLA PISTAUR, MALSA ROAD, KICHHA, UDHAMSINGH NAGAR, UTTARAKHAND-263148,INDIA, India
Manufacturer Name
Finecure Pharmaceuticals Limited
Manufacturer Country
INDIA
Approval Date
2023-03-28
Expiry Date
2028-03-27